Duke Cancer Network (@DukeCancerNETWK) header
Duke Cancer Network (@DukeCancerNETWK) profile picture

Duke Cancer Network

@DukeCancerNETWK

The Duke Cancer Network has expertise in building value-based programs that define best practices and enhance quality to best serve the needs of your community.

 United States
affiliations.dukehealth.org/services/cancer-network
Joined July 2016
  • Tweets198
  • Following44
  • Followers319
10Media
Photo by Duke Cancer Network (@DukeCancerNETWK)Photo by Duke Cancer Network (@DukeCancerNETWK)Photo by Duke Cancer Network (@DukeCancerNETWK)Photo by Duke Cancer Network (@DukeCancerNETWK)Photo by Duke Cancer Network (@DukeCancerNETWK)Photo by Duke Cancer Network (@DukeCancerNETWK)Photo by Duke Cancer Network (@DukeCancerNETWK)Photo by Duke Cancer Network (@DukeCancerNETWK)Photo by Duke Cancer Network (@DukeCancerNETWK)Photo by Duke Cancer Network (@DukeCancerNETWK)
Duke Cancer Network retweeted
Yousuf Zafar, MD MHS (@yzafar) profile picture
Yousuf Zafar, MD MHS@yzafar23 Feb 2019
For treatment of hepatocellular carcinoma, should cost impact the decision of resection vs transplantation? #DukeGIDebates
Image from Yousuf Zafar, MD MHS (@yzafar)
1
2
7
Duke Cancer Network retweeted
Yousuf Zafar, MD MHS (@yzafar) profile picture
Yousuf Zafar, MD MHS@yzafar23 Feb 2019
Mike Morse of ⁦@DukeCancer⁩ on why hepatocellular cancer is potentially susceptible to immunotherapy #DukeGIDebates
Image from Yousuf Zafar, MD MHS (@yzafar)
1
2
Duke Cancer Network retweeted
Yousuf Zafar, MD MHS (@yzafar) profile picture
Yousuf Zafar, MD MHS@yzafar23 Feb 2019
.@skopetz giving a master class in treatment of #colorectalcancer at #DukeGIDebates
Image from Yousuf Zafar, MD MHS (@yzafar)
1
6
17
Duke Cancer Network retweeted
Yousuf Zafar, MD MHS (@yzafar) profile picture
Yousuf Zafar, MD MHS@yzafar23 Feb 2019
In BRAF MT #colorectalcancer treated with vemurafenib/iri/cetux, selective pressure might cause progression due to deactivation of MAPK pathway #DukeGIDebates
Image from Yousuf Zafar, MD MHS (@yzafar)
Image from Yousuf Zafar, MD MHS (@yzafar)
1
Duke Cancer Network retweeted
Yousuf Zafar, MD MHS (@yzafar) profile picture
Yousuf Zafar, MD MHS@yzafar23 Feb 2019
Promising preliminary data from BEACON ( encorafenib + binimetinib + cetuximab) by @skopetz suggests possible new regimen for #colorectalcancer patients with BRAF MT #DukeGIDebates
Image from Yousuf Zafar, MD MHS (@yzafar)
Image from Yousuf Zafar, MD MHS (@yzafar)
2
4
Load more